Boyden’s Trevor Pritchard and Steve Nilsen placed Amy Efantis as new President and Chief Executive Officer of the Plasma Therapeutics Association (PPTA).
This article was originally published on Hunt-Scanlon Media’s website. Click here to view the original article.
January 31, 2019 – Global executive search firm Boyden has placed Amy Efantis as the new president and chief executive officer of the Plasma Protein Therapeutics Association (PPTA) in Annapolis, MD. Partners Trevor Pritchard and Steve Nilsen led the assignment for Boyden.
PPTA, a trade association, represents more than 750 human plasma collection centers in North America and Europe as well as the manufacturers of life-saving plasma protein therapies.
Ms. Efantis most recently served as vice president, global public policy and government affairs at Biogen.
“We are very pleased that Amy has agreed to take on the leadership for the PPTA at a time of unprecedented change in health care,” said David Bell, chairman of PPTA’s global board of directors and general counsel and chief innovation officer with Grifols SA. “Continued progress in the development of vital and life-saving treatments through the development of plasma protein therapies is critically dependent on the support needed from global stakeholders around the world. Amy has been selected by our board as we all believe she has the leadership and vision to set the course for PPTA’s future.”
Furthering the Mission
Ms. Efantis succeeds Jan M. Bult, who retired at the end of last year. “We have been honored to have Jan lead our organization and are deeply grateful for the extraordinary work that he and his team have contributed to the furtherance of the PPTA’s mission over these past twenty-three years,” said Mr. Bell. “We are excited to know that Amy will build upon the excellent foundation of the association.”
Prior to Biogen, Ms. Efantis held roles with Boehringer Ingelheim and PhRMA. She also worked on Capitol Hill as a congressional legislative director and, prior to that, advised former U.S. Rep. Thomas Barrett of Wisconsin on various House energy & commerce committee issues, primarily in healthcare policy.
“I am thrilled and honored to be joining the PPTA and the vital efforts of the plasma industry,” said Ms. Efantis. “To represent companies whose mission is serving patients with rare diseases that can be treated through the development of plasma-derived products is a stewardship role that I embrace with humility and a deeply felt passion.”
PPTA represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. Millions of people use these therapies worldwide to treat a variety of diseases and serious medical conditions. PPTA also administers standards and programs that help ensure the quality and safety of plasma protein therapies, donors and patients.
Boyden is a talent advisory and leadership solutions firm with more than 65 offices in over 40 countries. Founded in 1946, the firm specializes in high-level executive search, interim management and human capital consulting across a broad spectrum of industries.
Mr. Pritchard is North America leader of Boyden’s healthcare and life sciences practice and global leader for medtech. He has 20 years’ domain experience in the healthcare and life sciences sector, including senior management roles in global pharmaceutical and medical device companies, as well as 15 years’ executive recruiting experience.
Mr. Pritchard collaborates with boards, CEOs, hiring managers and staffing organizations on searches for board positions, CEOs, presidents and all functional levels across multiple life science verticals. He has a strong track record of identifying and recruiting research, scientific, regulatory, clinical/product development and technical leaders from leading academic institutions and within the industry.
Mr. Nilsen leads Boyden’s healthcare marketing and technology sub-practice. He has an extensive background in global brand building and marketing, highlighted by achievements in the consumer and healthcare and life sciences technology sectors. Having lived and worked in multiple continents, he offers his clients a global perspective. He has more than 20 years of experience in global business, including leadership roles with major international companies. His focus is senior management, C-suite and board appointments.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media